Observational studyEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026
Personalized predictive modeling of otitis media with effusion: a multivariable approach to individualized prognosis, hearing rehabilitation, and follow-up.
Observational study in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionOtitis media with effusion (OME) is a highly prevalent condition in pediatric patients, affecting up to 55% of children under two years of age. Several factors contribute to its development, including immature Eustachian tube function, allergic factors, and adenoidal obstruction, making treatment optimization challenging yet essential due to the potential consequences of this condition. The primary objective of this study is to analyze the influence of various etiological, clinical, and therapeutic variables on functional auditory outcomes using a binary logistic regression model. Secondarily, the study aims to identify whether these variables are associated with adverse outcomes such as the need for hearing aids or delayed language development.
methodsThis is a single-center, observational, descriptive, and retrospective cohort study conducted between 2020 and 2023, with a 12-month follow-up period. Functional outcomes, risk of complications, and their timing were analyzed, among other variables.
resultsA total of 95 patients were included, with a mean age of 3.82 ± 1.94 years, predominantly male (64.21%, n = 61) and with bilateral involvement (85.26%, n = 81). A mean hearing improvement of 9.07 ± 20.07 dB was observed at the end of the follow-up. Multivariable regression analysis revealed that the PTA at 6 months is a significant predictor of long-term auditory outcomes (p = 0.036), while adenoidectomy acts as a protective factor (p = 0.042). Chronic otitis media (COM), PTA at 12 months, and persistent OME were associated with a higher risk of requiring hearing aids (p = 0.036, 0.009, and 0.006, respectively), while the latter two were also linked to a greater risk of delayed language development (p = 0.030 and 0.011).
conclusionsThe study identifies that PTA at 12 months, COM, and persistent OME significantly increase the risk of needing hearing aids and speech therapy. Elevated PTA at 6 months is an early predictor of poor prognosis, while adenoidectomy, despite being a protective factor for auditory outcomes, may be associated with earlier complications. Evenmore, this work illustrates how real-world clinical and audiological data can be translated into actionable personalized care pathways, supporting more precise clinical decisions and improving long-term outcomes in children with OME.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.